ATOS Shares Outstanding History



Below is a table of the ATOS shares outstanding history going back to 4/20/2018:

Date ATOS Shares Outstanding
4/20/20182.65M
5/11/20182.65M
8/10/20185.07M
11/9/20185.65M
3/25/20199.12M
5/9/20199.12M
8/9/20199.13M
10/27/2015111944
11/11/20199.13M
3/24/20209.13M
5/8/20209.21M
8/10/202010.40M
11/9/202010.49M
3/24/2021120.82M
5/10/2021120.82M
8/6/2021126.62M
11/11/2021126.62M
2/18/2022126.62M
5/6/2022126.62M
8/5/2022126.62M
11/4/2022126.62M
3/16/2023126.62M
5/10/2023126.62M
8/10/2023125.79M
11/8/2023125.30M
3/15/2024125.30M
5/1/2024125.76M
8/1/2024125.76M
11/8/2024125.80M

Also see: ATOS Market Cap History
ATOS YTD Return
ATOS Historical Shares Outstanding:
+80.12% CAGR
ATOS Historical Shares Outstanding: +80.12% CAGR

Mouse over chart for data details
4/20/2018 ...11/8/2024
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing medicines in areas of significant unmet medical need in oncology with a focus on using (Z)-endoxifen to prevent and treat breast cancer. Its lead drug candidate under development is oral (Z)-endoxifen, which it is developing for both the prevention and treatment of breast cancer. (Z)-endoxifen is the potent Selective Estrogen Receptor Modulator for estrogen receptor inhibition and causes estrogen receptor degradation. In addition to its potent anti-estrogen effects, (Z)-endoxifen has been shown to target PKCB1, a known oncogenic protein, at clinically attainable blood concentrations. We show 29 historical shares outstanding datapoints in our coverage of ATOS's shares outstanding history.

Understanding the changing numbers of ATOS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ATOS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ATOS by allowing them to research ATOS shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ATOS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Atossa Genetics (ATOS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ATRA Shares Outstanding History
ATRC Shares Outstanding History
ATRI Shares Outstanding History
ATRS Shares Outstanding History
ATXI Shares Outstanding History
ATXS Shares Outstanding History
ATYR Shares Outstanding History
AURA Shares Outstanding History
AVAH Shares Outstanding History
AVBP Shares Outstanding History
More Healthcare companies »

 

ATOS Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.